C19-YRS is a validated screening tool used to assess the severity of common persistent symptoms identified in patients after contracting COVID-19, also known as ‘long COVID’ or ‘post-COVID syndrome’. The self-reporting tool has been developed by clinical academics at The University of Leeds using research gathered across the West Yorkshire region. The tool has been recommended for routine use by NHS England in their National Guidance for post-COVID syndrome assessment and also recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19. More details of the benefits offered by C19-YRS can be viewed through the product brochure accessible here.
Long COVID is a term used to describe a new and emerging condition faced by patients presenting with symptoms that develop during or after contracting COVID-19 and persist for more than 4 weeks according to NICE. The syndrome is still not yet fully understood, with symptoms of breathlessness, cough and severe fatigue being amongst the most prevalent symptoms. As of January 24th 2021 the World Health Organisation estimates there have 97.4 million confirmed cases of (acute) COVID-19, with the Office for National Statistics estimating that:
Around 20% of patients testing positive for COVID-19 exhibit symptoms for a period of 5 weeks or longer
Around 10% of patients testing positive for COVID-19 exhibit symptoms for a period of 12 weeks or longer
ELAROS’ C19-YRS boasts a secure web portal for clinicians to set up and manage patients to assist with the initial triage, assessment and short-to-long-term monitoring process using graded scores for a spectrum of symptoms and grouped scores for symptom severity, functional disability and overall health. Extensive reporting tools help support health organisations better deploy, evidence and account for the complex mix of resources used for long COVID patients.
This is a not for profit initiative for all NHS organisations.
Patients can access the questionnaire following referral from their healthcare professional, available on iOS and Android or any internet web browser, allowing them to track their condition with a quantitative assessment of improvement or deterioration. The platform seeks to improve patient outcomes, clinical intervention methods and help to understand long COVID as a condition by providing The University of Leeds’ research team with anonymised data to further validate the scale and develop a robust measure of the condition.
Scoring of symptom severity and functional disability performance
Easy to use, secure and scalable platform to oversee patients
User friendly with visual aids for patients to monitor recovery progress
The system is free to purchase for all